{"mainPropery":{"diseaseId":9644,"diseaseName":"Multicentric Castleman Disease","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9644/multicentric-castleman-disease","synonyms":["MCD","Plasmablastic multicentric Castleman disease","PMCD","Multicentric plasma cell variant of Castleman's disease","Idiopathic multicentric Castleman's disease","Multicentric giant lymph node hyperplasia"],"synonyms-with-source":[{"name":"MCD"},{"name":"Plasmablastic multicentric Castleman disease"},{"name":"PMCD"},{"name":"Multicentric plasma cell variant of Castleman's disease"},{"name":"Idiopathic multicentric Castleman's disease"},{"name":"Multicentric giant lymph node hyperplasia","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"93686"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases","source":"Orphanet"},{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"},{"diseaseTypeId":25,"diseaseTypeName":"Viral infections"}],"organizations":[{"resourceID":120,"resourceName":"American Cancer Society","abbreviation":"","address1":"250 Williams Street NW","address2":"","address3":"","address4":"","address5":"","city":"Atlanta","state":"GA","zip":"30329","country":"United States","phone":"","tty":"","tollFree":"1-800-227-2345","fax":"","email":"","url":"https://www.cancer.org","freeText":""},{"resourceID":3061,"resourceName":"Castleman Disease Collaborative Network","abbreviation":"","address1":"P.O. Box 3614","address2":"","address3":"","address4":"","address5":"","city":"Paso Robles","state":"CA","zip":"93447","country":"","phone":"+1-610-304-0696 (for patients and families)","tty":"","tollFree":"","fax":"","email":"info@castlemannetwork.org","url":"https://cdcn.org/","freeText":"Office phone: +1-215-614-0935"}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=Multicentric%20Castleman%20disease%5Bti%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Multicentric Castleman Disease. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='https://www.clinicaltrials.gov/ct2/results?term=multicentric+castleman+disease&Search=Search' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Multicentric Castleman Disease. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":772,"resourceId":120,"resourceName":"American Cancer Society","descriptionText":"The&nbsp;<a href='http://www.cancer.org/Cancer/CastlemanDisease/DetailedGuide/index ' target='_blank'>American Cancer Society</a> provides detailed information about Multicentric Castleman Disease. Click on the link to access this information.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":775,"resourceId":1860,"resourceName":"Mayo Clinic","descriptionText":"<a href='http://www.mayoclinic.com/health/castleman-disease/DS01000/METHOD=print' target='_blank'>Mayo Clinic</a> has an information page on Multicentric Castleman Disease.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/532/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/2219018-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022625' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=93686' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1542,"resourceId":2170,"resourceName":"RePORTER","descriptionText":"The <a href='http://projectreporter.nih.gov/reporter.cfm' target='_blank'>Research Portfolio Online Reporting Tool (RePORT)</a> provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research.  Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, enter the disease name in the \"Text Search\" box.  Then click \"Submit Query\".","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:148000' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2691,"resourceId":3061,"resourceName":"Castleman Disease Collaborative Network","descriptionText":"The&nbsp;<a href='https://www.cdcn.org/about-castleman-disease' target='_blank'>Castleman Disease Collaborative Network</a>, a global initiative dedicated to accelerating research and treatment for Castleman disease, provides information about&nbsp;Multicentric Castleman Disease.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"}],"overviewQuestion":{"questionId":2744,"questionText":"What is multicentric Castleman disease?","answerText":"<strong>Multicentric Castleman disease (MCD)</strong> is a rare disease that affects the <a href=\"http://www.nlm.nih.gov/medlineplus/lymphaticdiseases.html\" target=\"_blank\">lymph nodes</a> and related tissues. It is a form of <a href=\"https://rarediseases.info.nih.gov/gard/12656/castleman-disease/resources/1\" target=\"_blank\">Castleman disease</a> that is \"systemic\" and involves multiple regions of lymph nodes (as opposed to <a href=\"https://rarediseases.info.nih.gov/gard/6005/unicentric-castleman-disease/resources/1\" target=\"_blank\">unicentric Castleman disease</a>, which involves a single lymph node or single region of lymph nodes). The signs and symptoms of MCD are often nonspecific, and are mild in some people but life-threatening in others.[15040][15038] Symptoms may include  enlarged lymph nodes in multiple regions,   fever, weight loss, nausea, rash, and/or an enlarged large liver and spleen.[15040][15038] The disease is diagnosed based on the symptoms present, laboratory test results, imaging studies, and results of a biopsy of the lymph nodes which shows specific features when studied under the microscope.[15040] In some cases, MCD is caused by&nbsp;<a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms/def/human-herpesvirus-8\" target=\"_blank\">human herpesvirus-8</a> (HHV-8) and is referred to as HHV-8-associated MCD. In other cases, the cause is not known and it is referred to as&nbsp;HHV-8 negative MCD, or idiopathic MCD (iMCD).[15040][15038] Treatment of MCD is challenging, and treatment options and outcomes depend on the type and severity  in each person.[15038]","dateModified":"2018-11-05T00:00:00"},"basicQuestions":[{"questionId":5089,"questionText":"What are the signs and symptoms of multicentric Castleman disease?","answerText":"The signs and symptoms of multicentric Castleman disease (MCD) are often nonspecific and blamed on other, more common conditions. They can vary but may include:[9148][9150][9168]\r\n<ul>\r\n    <li>Fever</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003097.htm\" target=\"_blank\">Enlarged lymph nodes</a></li>\r\n    <li>Night sweats</li>\r\n    <li>Loss of appetite and weight loss</li>\r\n    <li>Weakness and <a href=\"http://www.nlm.nih.gov/medlineplus/fatigue.html\" target=\"_blank\">fatigue</a></li>\r\n    <li>Shortness of breath</li>\r\n    <li>Nausea and vomiting</li>\r\n    <li>Enlarged liver or spleen</li>\r\n    <li><a href=\"http://www.ninds.nih.gov/disorders/peripheralneuropathy/detail_peripheralneuropathy.htm\" target=\"_blank\">Peripheral neuropathy</a></li>\r\n    <li>Skin abnormalities such as rashes and/or <a href=\"http://www.nlm.nih.gov/medlineplus/pemphigus.html\" target=\"_blank\">pemphigus</a></li>\r\n</ul>\r\n<br />\r\nLess commonly (&lt;10% of cases), people affected by MCD will have no signs or symptoms of the condition.[9150]<br />\r\n<br />\r\nOther conditions associated with MCD include <a href=\"http://www.nlm.nih.gov/medlineplus/amyloidosis.html\" target=\"_blank\">amyloidosis</a>, <a href=\"https://rarediseases.info.nih.gov/gard/7411/poems-syndrome/resources/1\" target=\"_blank\">POEMS syndrome</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000816.htm\" target=\"_blank\">autoimmune disease</a>, <a href=\"http://www.nhlbi.nih.gov/health/health-topics/topics/ha/\" target=\"_blank\">hemolytic anemia</a>, and&nbsp;<a href=\"https://rarediseases.info.nih.gov/gard/5194/idiopathic-thrombocytopenic-purpura/resources/1\" target=\"_blank\">immune thrombocytopenic purpura</a> (ITP).[9150]","dateModified":"2015-06-25T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":9148,"authors":"","articleTitle":"Castleman disease","bookWebsiteJournalTitle":"Mayo Clinic","date":"August 2014","volume":"","pages":"","url":"http://www.mayoclinic.org/diseases-conditions/castleman-disease/basics/definition/con-20031703?p=1","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9150,"authors":"Neetu Radhakrishnan, MD","articleTitle":"Castleman Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"January 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/2219018-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9168,"authors":"Jon C Aster, MD; Jennifer R Brown, MD, PhD; Nikhil C Munshi, MD","articleTitle":"Multicentric Castleman's disease","bookWebsiteJournalTitle":"UpToDate","date":"January 2015","volume":"","pages":"","url":"","dateAccessed":"2015-06-25T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9001,"questionText":"What causes multicentric Castleman disease?","answerText":"In about half of people with multicentric Castleman disease (MCD), it is caused by <a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms/def/human-herpesvirus-8\" target=\"_blank\">human herpesvirus-8</a> (HHV-8), in which case it is called HHV-8-associated MCD.[15040][15038] This type of MCD usually occurs in people with human immunodeficiency virus (HIV) or a weakened immune system due to other reasons, because the weakened immune system is not able to manage a HHV-8 infection.[15040] It is thought that the infection  multiplies in the lymph nodes, leading to the release of high levels of inflammatory chemicals (particularly <a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cytokine\" target=\"_blank\">cytokines</a>&nbsp;such as <a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms/def/interleukin-6\" target=\"_blank\">interleukin-6</a>), causing the specific symptoms of MCD.[15041]<br />\r\n<br />\r\nIn the remaining half of cases of MCD, the cause is not known, in which case it is called HHV-8 negative MCD, or idiopathic MCD (iMCD).[15040][15038] Possible factors that have been speculated to play a role in causing iMCD include being infected with a virus other than HHV-8, acquiring a genetic mutation that signals the release of substances that lead to the disease, inheriting a genetic mutation that predisposes a person to developing the disease, and&nbsp;<a href=\"https://kidshealth.org/en/parents/autoimmunity.html\" target=\"_blank\">autoimmunity</a>&nbsp;(when the body's immune system mistakenly attacks healthy tissues).[15040][15041] People with iMCD often also have high levels of cytokines, but the cause of their increased production in iMCD is not yet known.[15041]","dateModified":"2018-11-06T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":15038,"authors":"van Rhee F, Voorhees P, Dispenzieri A, et al","articleTitle":"International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease","bookWebsiteJournalTitle":"Blood","date":"September 4, 2018","volume":"[Epub ahead of print]","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/30181172","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15040,"authors":"","articleTitle":"Castleman Disease","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2017","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/castlemans-disease/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15041,"authors":"","articleTitle":"About Castleman Disease","bookWebsiteJournalTitle":"Castleman Disease Collaborative Network (CDCN)","date":"","volume":"","pages":"","url":"https://www.cdcn.org/about-castleman-disease","dateAccessed":"2018-11-06T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9004,"questionText":"Is multicentric Castleman disease inherited?","answerText":"To our knowledge, there is no evidence that multicentric Castleman disease is an inherited disease.","dateModified":"2018-11-06T00:00:00","resourceClassificationName":"Inheritance","references":[]},{"questionId":9006,"questionText":"How is multicentric Castleman disease diagnosed?","answerText":"The <a href=\"https://rarediseases.info.nih.gov/gard/9644/multicentric-castleman-disease/resources/9\" target=\"_blank\">signs and symptoms</a> of multicentric Castleman disease (MCD) are often nonspecific and blamed on other, more common conditions. However, if MCD is suspected, the following tests may be recommended to help establish the diagnosis and rule out other conditions that cause similar features:[9150][9168]\r\n<ul>\r\n    <li>Blood tests can be ordered to evaluate the levels of Interleukin-6 (IL-6) and other substances in the body, which can be elevated in people with MCD. They can also be helpful in ruling out other <a href=\"http://www.nlm.nih.gov/medlineplus/autoimmunediseases.html\" target=\"_blank\">autoimmune conditions</a> and infections that are associated with similar signs and symptoms</li>\r\n    <li>Imaging studies (such as a <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003330.htm\" target=\"_blank\">CT scan</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003827.htm\" target=\"_blank\">PET scan</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/mriscans.html\" target=\"_blank\">MRI scan</a>, and/or <a href=\"http://www.nlm.nih.gov/medlineplus/ultrasound.html\" target=\"_blank\">ultrasound</a>) can help identify enlarged lymph node(s) and other health problems</li>\r\n    <li>A biopsy of affected tissue, often a <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003933.htm\" target=\"_blank\">lymph node</a>, is usually recommended to confirm the diagnosis</li>\r\n</ul>","dateModified":"2015-06-25T14:23:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":9150,"authors":"Neetu Radhakrishnan, MD","articleTitle":"Castleman Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"January 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/2219018-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9168,"authors":"Jon C Aster, MD; Jennifer R Brown, MD, PhD; Nikhil C Munshi, MD","articleTitle":"Multicentric Castleman's disease","bookWebsiteJournalTitle":"UpToDate","date":"January 2015","volume":"","pages":"","url":"","dateAccessed":"2015-06-25T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4304,"questionText":"How might multicentric Castleman disease be treated?","answerText":"Treatment of multicentric Castleman disease (MCD) is challenging, and no single treatment works for all people with the disease.[15042] Treatment options may depend on the type of MCD (HHV-8-associated or idiopathic) as well as the severity of symptoms.<br />\r\n<br />\r\nHHV-8-associated MCD is typically initially treated with <a href=\"https://www.mayoclinic.org/drugs-supplements/rituximab-intravenous-route/description/drg-20068057\" target=\"_blank\">rituximab</a> to fight against immune cells called B lymphocytes. This treatment is reportedly highly effective for HHV-8-associated MCD. <a href=\"https://www.cancer.org/cancer/castleman-disease/treating/antiviral-drugs.html\" target=\"_blank\">Antiviral medications</a> (particularly for those with HIV) and/or <a href=\"https://www.cancer.org/cancer/castleman-disease/treating/chemotherapy.html\" target=\"_blank\">chemotherapy</a> may also be recommended.[15040]<br />\r\n<br />\r\nIdiopathic MCD (iMCD) is typically initially treated with&nbsp;<a href=\"https://www.cancer.gov/about-cancer/treatment/drugs/siltuximab\" target=\"_blank\">siltuximab</a> or <a href=\"https://www.cancer.gov/about-cancer/treatment/drugs/tocilizumab\" target=\"_blank\">tocilizumab</a> (which aim to control activity of interleukin-6) with or without corticosteroids. Unfortunately, about half of people do not improve with these therapies. In those with only mild symptoms, rituximab may be an alternative option for initial treatment. In very severe cases, <a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adjuvant-therapy\" target=\"_blank\">adjuvant combination chemotherapy</a> is also recommended. Other types of therapies may be recommended if the above therapies are not effective.[15038]","dateModified":"2018-11-06T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":15038,"authors":"van Rhee F, Voorhees P, Dispenzieri A, et al","articleTitle":"International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease","bookWebsiteJournalTitle":"Blood","date":"September 4, 2018","volume":"[Epub ahead of print]","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/30181172","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15040,"authors":"","articleTitle":"Castleman Disease","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2017","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/castlemans-disease/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15042,"authors":"","articleTitle":"Treatment of Multicentric Castleman Disease","bookWebsiteJournalTitle":"American Cancer Society","date":"January 12, 2017","volume":"","pages":"","url":"https://www.cancer.org/cancer/castleman-disease/treating.html","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9009,"questionText":"What is the long-term outlook for people with multicentric Castleman disease?","answerText":"The long-term outlook (prognosis) for people with multicentric Castleman disease (MCD) varies. In some cases, the condition may persist for several months or years without progressing (worsening overtime). Other people affected by MCD experience episodes of severe symptoms that may improve spontaneously or in response to treatment, only to recur at a later date. People with MCD who are also <a href=\"http://www.nlm.nih.gov/medlineplus/hivaids.html\" target=\"_blank\">HIV-positive</a> may be at an elevated risk for a severe form that is rapidly progressive and can lead to death within weeks.[9150][9168] <br />\r\n<br />\r\nIn general, the prognosis is worse in affected people who do not receive appropriate treatment and in those with HIV-associated MCD.[9150]","dateModified":"2015-06-25T20:45:00","resourceClassificationName":"Prognosis","references":[{"referenceId":9150,"authors":"Neetu Radhakrishnan, MD","articleTitle":"Castleman Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"January 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/2219018-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9168,"authors":"Jon C Aster, MD; Jennifer R Brown, MD, PhD; Nikhil C Munshi, MD","articleTitle":"Multicentric Castleman's disease","bookWebsiteJournalTitle":"UpToDate","date":"January 2015","volume":"","pages":"","url":"","dateAccessed":"2015-06-25T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12656,"relatedDiseaseName":"Castleman disease","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":31886,"abbreviatedInquiry":"Does the multicentric form of Castleman's disease always&nbsp;cause symptoms?","caseQuestions":[{"questionId":5089,"questionText":"What are the signs and symptoms of multicentric Castleman disease?","answerText":"The signs and symptoms of multicentric Castleman disease (MCD) are often nonspecific and blamed on other, more common conditions. They can vary but may include:[9148][9150][9168]\r\n<ul>\r\n    <li>Fever</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003097.htm\" target=\"_blank\">Enlarged lymph nodes</a></li>\r\n    <li>Night sweats</li>\r\n    <li>Loss of appetite and weight loss</li>\r\n    <li>Weakness and <a href=\"http://www.nlm.nih.gov/medlineplus/fatigue.html\" target=\"_blank\">fatigue</a></li>\r\n    <li>Shortness of breath</li>\r\n    <li>Nausea and vomiting</li>\r\n    <li>Enlarged liver or spleen</li>\r\n    <li><a href=\"http://www.ninds.nih.gov/disorders/peripheralneuropathy/detail_peripheralneuropathy.htm\" target=\"_blank\">Peripheral neuropathy</a></li>\r\n    <li>Skin abnormalities such as rashes and/or <a href=\"http://www.nlm.nih.gov/medlineplus/pemphigus.html\" target=\"_blank\">pemphigus</a></li>\r\n</ul>\r\n<br />\r\nLess commonly (&lt;10% of cases), people affected by MCD will have no signs or symptoms of the condition.[9150]<br />\r\n<br />\r\nOther conditions associated with MCD include <a href=\"http://www.nlm.nih.gov/medlineplus/amyloidosis.html\" target=\"_blank\">amyloidosis</a>, <a href=\"https://rarediseases.info.nih.gov/gard/7411/poems-syndrome/resources/1\" target=\"_blank\">POEMS syndrome</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000816.htm\" target=\"_blank\">autoimmune disease</a>, <a href=\"http://www.nhlbi.nih.gov/health/health-topics/topics/ha/\" target=\"_blank\">hemolytic anemia</a>, and&nbsp;<a href=\"https://rarediseases.info.nih.gov/gard/5194/idiopathic-thrombocytopenic-purpura/resources/1\" target=\"_blank\">immune thrombocytopenic purpura</a> (ITP).[9150]","dateModified":"2015-06-25T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":9148,"authors":"","articleTitle":"Castleman disease","bookWebsiteJournalTitle":"Mayo Clinic","date":"August 2014","volume":"","pages":"","url":"http://www.mayoclinic.org/diseases-conditions/castleman-disease/basics/definition/con-20031703?p=1","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9150,"authors":"Neetu Radhakrishnan, MD","articleTitle":"Castleman Disease","bookWebsiteJournalTitle":"Medscape Reference","date":"January 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/2219018-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9168,"authors":"Jon C Aster, MD; Jennifer R Brown, MD, PhD; Nikhil C Munshi, MD","articleTitle":"Multicentric Castleman's disease","bookWebsiteJournalTitle":"UpToDate","date":"January 2015","volume":"","pages":"","url":"","dateAccessed":"2015-06-25T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}]},{"caseId":30173,"abbreviatedInquiry":"How might multicentric Castleman's disease be treated?","caseQuestions":[{"questionId":4304,"questionText":"How might multicentric Castleman disease be treated?","answerText":"Treatment of multicentric Castleman disease (MCD) is challenging, and no single treatment works for all people with the disease.[15042] Treatment options may depend on the type of MCD (HHV-8-associated or idiopathic) as well as the severity of symptoms.<br />\r\n<br />\r\nHHV-8-associated MCD is typically initially treated with <a href=\"https://www.mayoclinic.org/drugs-supplements/rituximab-intravenous-route/description/drg-20068057\" target=\"_blank\">rituximab</a> to fight against immune cells called B lymphocytes. This treatment is reportedly highly effective for HHV-8-associated MCD. <a href=\"https://www.cancer.org/cancer/castleman-disease/treating/antiviral-drugs.html\" target=\"_blank\">Antiviral medications</a> (particularly for those with HIV) and/or <a href=\"https://www.cancer.org/cancer/castleman-disease/treating/chemotherapy.html\" target=\"_blank\">chemotherapy</a> may also be recommended.[15040]<br />\r\n<br />\r\nIdiopathic MCD (iMCD) is typically initially treated with&nbsp;<a href=\"https://www.cancer.gov/about-cancer/treatment/drugs/siltuximab\" target=\"_blank\">siltuximab</a> or <a href=\"https://www.cancer.gov/about-cancer/treatment/drugs/tocilizumab\" target=\"_blank\">tocilizumab</a> (which aim to control activity of interleukin-6) with or without corticosteroids. Unfortunately, about half of people do not improve with these therapies. In those with only mild symptoms, rituximab may be an alternative option for initial treatment. In very severe cases, <a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adjuvant-therapy\" target=\"_blank\">adjuvant combination chemotherapy</a> is also recommended. Other types of therapies may be recommended if the above therapies are not effective.[15038]","dateModified":"2018-11-06T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":15038,"authors":"van Rhee F, Voorhees P, Dispenzieri A, et al","articleTitle":"International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease","bookWebsiteJournalTitle":"Blood","date":"September 4, 2018","volume":"[Epub ahead of print]","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/30181172","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15040,"authors":"","articleTitle":"Castleman Disease","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2017","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/castlemans-disease/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15042,"authors":"","articleTitle":"Treatment of Multicentric Castleman Disease","bookWebsiteJournalTitle":"American Cancer Society","date":"January 12, 2017","volume":"","pages":"","url":"https://www.cancer.org/cancer/castleman-disease/treating.html","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[{"productId":602,"genericName":"siltuximab","tradeName":"Sylvant","tradeLink":"http://www.sylvant.com/","manufacturer":"","sponsor":"Janssen Biotech, Inc.","indication":"Treatment of patients with multicentric Castleman's disease (MCD) who are human immunodeficiency virus (HIV) negative and human herpesvirus-8 (HHV-8) negative.","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=SYLVANT","medlinePlusLink":"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a614028.html"}],"EncodedName":"Multicentric_Castleman_Disease"}